StacksVerified U.S. regulatory reference

48 CFR §27.204-1

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.